White label ELPA - ClinicalTrials.eu

Study on Reducing Tacrolimus Dose in Kidney Transplant Patients Using LCPT Compared to Tacrolimus-ER

Not recruiting

3 1 1 1
Investigated diseases:
- Renal failure
- Renal transplant
Investigated drugs:
- Tacrolimus
Study of Modified Anti-Platelet Therapy with Prasugrel, Ticagrelor, and Clopidogrel in Heart Attack Patients Undergoing Complete Revascularization

Not recruiting

3 1 1 1
Investigated diseases:
- Acute myocardial infarction
Investigated drugs:
Study on the Safety of Levobupivacaine and Bupivacaine with Fentanyl for Anesthesia in Patients Over 65 Undergoing Hip Fracture Surgery

Not recruiting

3 1 1 1
Investigated diseases:
- Hip fracture
Investigated drugs:
Study of Long-Acting Cabotegravir and Rilpivirine for People Aged 60 and Over Living with HIV-1

Not recruiting

3 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
- Cabotegravir
- Rilpivirine
Study of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome

Not recruiting

3 1 1
Investigated diseases:
- Stress cardiomyopathy
Investigated drugs:
- Glucose Monohydrate
- Levosimendan
Study on Radiometabolic Therapy with 177Lu-PSMA for Patients with Advanced or Metastatic Tumors

Not recruiting

2 1 1
Investigated diseases:
- Prostate cancer
Investigated drugs:
- 177LU-PSMA-I&T
Study on Long-Term Safety of Tegoprubart and Tacrolimus for Preventing Kidney Transplant Rejection in Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Kidney transplant rejection
Investigated drugs:
- At-1501
- Tacrolimus
PET Imaging Study for Large B-Cell Lymphoma Patients Using 89Zr-CED88004S Before and After CAR T-Cell Therapy

Not recruiting

4 1 1
Investigated diseases:
- B-cell lymphoma
Investigated drugs:
- 89ZR-CED88004S
Study on the Safety of Carbetocin Nasal Spray for Treating Uncontrollable Hunger in Patients with Prader-Willi Syndrome

Not recruiting

3 1 1
Investigated drugs:
- Carbetocin
Study of Lorlatinib for Patients with ALK+ Anaplastic Large Cell Lymphoma After Ineffective ALK Inhibitor Treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Anaplastic large cell lymphoma T- and null-cell types
Investigated drugs:
- Lorlatinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies